capsensixx AG (CPX) - Net Assets
Based on the latest financial reports, capsensixx AG (CPX) has net assets worth €26.11 Million EUR as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€49.01 Million) and total liabilities (€22.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €26.11 Million |
| % of Total Assets | 53.27% |
| Annual Growth Rate | 12.07% |
| 5-Year Change | 26.79% |
| 10-Year Change | N/A |
| Growth Volatility | 16.38 |
capsensixx AG - Net Assets Trend (2016–2024)
This chart illustrates how capsensixx AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for capsensixx AG (2016–2024)
The table below shows the annual net assets of capsensixx AG from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €24.67 Million | +1.41% |
| 2023-12-31 | €24.32 Million | -1.66% |
| 2022-12-31 | €24.74 Million | +20.00% |
| 2021-12-31 | €20.61 Million | +5.95% |
| 2020-12-31 | €19.46 Million | +4.76% |
| 2019-12-31 | €18.57 Million | +5.19% |
| 2018-12-31 | €17.66 Million | +52.44% |
| 2017-12-31 | €11.58 Million | +16.85% |
| 2016-12-31 | €9.91 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to capsensixx AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 512.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €12.03 Million | 71.66% |
| Other Components | €4.76 Million | 28.34% |
| Total Equity | €16.79 Million | 100.00% |
capsensixx AG Competitors by Market Cap
The table below lists competitors of capsensixx AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BEST SPAC I Acquisition Corp. Class A Ordinary Shares
NASDAQ:BSAA
|
$61.87 Million |
|
AFC Gamma Inc
NASDAQ:AFCG
|
$61.88 Million |
|
China Fangda Group Co Ltd
SHE:200055
|
$61.89 Million |
|
Ginar Technology Co Ltd
TWO:6151
|
$61.89 Million |
|
Gseven Co Ltd
TWO:2937
|
$61.87 Million |
|
Thermaltake Technology Co Ltd
TWO:3540
|
$61.87 Million |
|
Endurance Gold Corp
V:EDG
|
$61.85 Million |
|
HEALTH NET
F:HNT
|
$61.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in capsensixx AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 16,366,000 to 16,787,000, a change of 421,000 (2.6%).
- Net income of 2,850,000 contributed positively to equity growth.
- Dividend payments of 1,047,000 reduced retained earnings.
- Share repurchases of 1,640,000 reduced equity.
- Other factors increased equity by 258,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €2.85 Million | +16.98% |
| Dividends Paid | €1.05 Million | -6.24% |
| Share Repurchases | €1.64 Million | -9.77% |
| Other Changes | €258.00K | +1.54% |
| Total Change | €- | 2.57% |
Book Value vs Market Value Analysis
This analysis compares capsensixx AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.12x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 12.95x to 4.12x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €1.73 | €22.40 | x |
| 2018-12-31 | €3.24 | €22.40 | x |
| 2019-12-31 | €3.40 | €22.40 | x |
| 2020-12-31 | €3.68 | €22.40 | x |
| 2021-12-31 | €3.65 | €22.40 | x |
| 2022-12-31 | €4.82 | €22.40 | x |
| 2023-12-31 | €5.30 | €22.40 | x |
| 2024-12-31 | €5.43 | €22.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently capsensixx AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.98%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.80%
- • Asset Turnover: 2.70x
- • Equity Multiplier: 3.49x
- Recent ROE (16.98%) is below the historical average (23.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 40.44% | 3.12% | 2.63x | 4.93x | €1.55 Million |
| 2017 | 42.62% | 2.17% | 2.04x | 9.62x | €1.94 Million |
| 2018 | 11.42% | 1.10% | 3.49x | 2.99x | €158.07K |
| 2019 | 20.68% | 2.15% | 2.66x | 3.62x | €1.25 Million |
| 2020 | 18.56% | 2.04% | 2.20x | 4.14x | €1.04 Million |
| 2021 | 24.95% | 1.67% | 1.79x | 8.33x | €1.80 Million |
| 2022 | 19.11% | 2.38% | 2.71x | 2.97x | €1.36 Million |
| 2023 | 18.00% | 2.32% | 2.64x | 2.94x | €1.31 Million |
| 2024 | 16.98% | 1.80% | 2.70x | 3.49x | €1.17 Million |
Industry Comparison
This section compares capsensixx AG's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $21,065,583,785
- Average return on equity (ROE) among peers: 8.78%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| capsensixx AG (CPX) | €26.11 Million | 40.44% | 0.88x | $61.87 Million |
| China Cinda Asset Management Co., Ltd. (0CI) | $208.00 Billion | 3.04% | 6.77x | $1.84 Billion |
| Quinsam Capital Corporation (0Q4) | $19.32 Million | 8.74% | 0.00x | $2.19 Million |
| Anima Holding SpA (124) | $1.66 Billion | 13.72% | 0.62x | $2.25 Billion |
| tokentus investment AG (14D) | $2.19 Million | -21.54% | 0.09x | $7.55 Million |
| doValue S.p.A. (1DB0) | $194.00 Million | 12.24% | 5.11x | $403.67 Million |
| AUSTRALIAN ETHICAL INV. (1OP) | $24.66 Million | 38.56% | 0.70x | $338.77 Million |
| IDUN INDUSTRIER AB B (1W6) | $665.26 Million | 4.74% | 1.57x | $281.92 Million |
| GOAT Industries Ltd. (26B) | $-830.34K | 0.00% | 0.00x | $5.18 Million |
| Hunter Capital AB (publ) (2DD0) | $32.05 Million | 25.75% | 0.04x | $4.90 Million |
| 2INVEST AG NA O.N. (2INV) | $63.16 Million | 2.50% | 0.02x | $53.38 Million |
About capsensixx AG
capsensixx AG engages in the financial administration as a service business. It operates through Funds Management, Administration & Accounting, and Capital Markets & Corporate Services segments. The company provides fund management, administration, and accounting services. It also offers securitization corporate and capital markets services. capsensixx AG was founded in 2017 and is based in Frank… Read more